Susanna Y. Cheng

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer

Shirish M. Gadgeel, Delvys Rodríguez‐Abreu, Giovanna Speranza et al. · Journal of Clinical Oncology · 2020 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet Oncology · 2019 · 85 citations · Full text

Medicine, Oncology, Pharmacology +16

Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?

Tomás Merino Lara, Joelle Helou, Ian Poon et al. · Lung Cancer · 2018 · 50 citations

Medicine, Oncology, Radiation Oncology +14

Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy.

Leigha Rowbottom, Jordan A. Stinson, Rachel McDonald et al. · PubMed · 2015 · 27 citations

Medicine, Oncology, Pharmacology +17

Anti-tumor activity, safety and pharmacokinetics (PK) of AGS15E (ASG-15ME) in a phase I dose escalation trial in patients (Pts) with metastatic urothelial cancer (mUC).

Daniel P. Petrylak, Elisabeth I. Heath, Guru Sonpavde et al. · Journal of Clinical Oncology · 2016 · 10 citations

Medicine, Oncology, Pharmacology +17